Insider Transactions in Q2 2023 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2023
|
David O. Watson General Counsel |
BUY
Bona fide gift
|
Indirect |
12,750
+13.64%
|
-
|
|
Jun 28
2023
|
David O. Watson General Counsel |
SELL
Bona fide gift
|
Direct |
12,750
-11.91%
|
-
|
|
Jun 20
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.46%
|
$110,000
$88.41 P/Share
|
|
Jun 20
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.46%
|
$2,500
$2.67 P/Share
|
|
Jun 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.14%
|
$1,092,000
$91.35 P/Share
|
|
Jun 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.73%
|
$37,000
$2.67 P/Share
|
|
Jun 05
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
69,779
-14.1%
|
$6,210,331
$89.15 P/Share
|
|
Jun 05
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,779
+32.12%
|
$697,790
$10.03 P/Share
|
|
Jun 01
2023
|
Karen Lewis Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.75%
|
$430,000
$86.0 P/Share
|
|
Jun 01
2023
|
Karen Lewis Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.71%
|
$170,000
$34.11 P/Share
|
|
May 24
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
20,000
+2.97%
|
-
|
|
May 24
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
20,000
-6.79%
|
-
|
|
May 17
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.36%
|
$40,000
$2.67 P/Share
|
|
May 17
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.46%
|
$110,000
$88.66 P/Share
|
|
May 17
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.46%
|
$2,500
$2.67 P/Share
|
|
May 16
2023
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.7%
|
$2,550,000
$85.43 P/Share
|
|
May 16
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+8.96%
|
$60,000
$2.67 P/Share
|
|
May 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.15%
|
$1,104,000
$92.39 P/Share
|
|
May 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.74%
|
$37,000
$2.67 P/Share
|
|
May 03
2023
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.17%
|
$410,000
$82.71 P/Share
|
|
May 03
2023
|
Adam J. Townsend Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.81%
|
$75,000
$15.09 P/Share
|
|
May 03
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
20,000
+26.24%
|
-
|
|
May 03
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
20,000
-20.47%
|
-
|
|
Apr 27
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
382,946
+50.0%
|
-
|
|
Apr 27
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
382,946
-58.23%
|
-
|
|
Apr 21
2023
|
David O. Watson General Counsel |
BUY
Bona fide gift
|
Indirect |
67,955
+50.0%
|
-
|
|
Apr 21
2023
|
David O. Watson General Counsel |
SELL
Bona fide gift
|
Direct |
67,955
-38.84%
|
-
|
|
Apr 19
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.95%
|
$40,000
$2.67 P/Share
|
|
Apr 19
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
36,232
+50.0%
|
-
|
|
Apr 19
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
36,232
-27.05%
|
-
|
|
Apr 18
2023
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-4.49%
|
$2,460,000
$82.02 P/Share
|
|
Apr 18
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.3%
|
$60,000
$2.67 P/Share
|
|
Apr 17
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.46%
|
$101,250
$81.05 P/Share
|
|
Apr 17
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.46%
|
$2,500
$2.67 P/Share
|
|
Apr 10
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.15%
|
$936,000
$78.21 P/Share
|
|
Apr 10
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.75%
|
$37,000
$2.67 P/Share
|
|
Apr 05
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
26,990
+4.08%
|
-
|
|
Apr 05
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
26,990
-4.06%
|
-
|
|
Apr 04
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
380,000
+38.49%
|
-
|
|
Apr 04
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
380,000
-36.38%
|
-
|
|
Apr 03
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
227,221
+50.0%
|
-
|
|
Apr 03
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
227,221
-17.87%
|
-
|
|
Apr 03
2023
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Direct |
500
-0.38%
|
$37,000
$74.05 P/Share
|
|
Apr 03
2023
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.17%
|
$370,000
$74.05 P/Share
|
|
Apr 03
2023
|
Adam J. Townsend Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.81%
|
$75,000
$15.09 P/Share
|
|
Apr 03
2023
|
Karen Lewis Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.77%
|
$375,000
$75.0 P/Share
|
|
Apr 03
2023
|
Karen Lewis Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.72%
|
$170,000
$34.11 P/Share
|